Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

NCT02546310 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: HTL0009936
DRUG: HTL0009936 matching placebo

Sponsor

Nxera Pharma UK Limited

Collaborators

[object Object]